Thus, the use of isoform specific antibodies unveiled different patterns of Sept9 isoform expression and the strong down-regulation of Sept9_i2 in breast tumors, not detectable with pan-Sept9 antibodies. This evidence concerns the gene SEPTIN9 and breast neoplasm.